Clinical InformationSedation using dexmedetomidine and REMIFENTANIL (cas 132875-61-7) with local anesthesia for intraoperative speech monitoring: a case reportSedação com dexmedetomidina e REMIFENTANIL (cas 132875-61-7) em anestesia local para monitoração intraoperatória da fala: um relato de caso

Add time:09/04/2019    Source:sciencedirect.com

Background and objectiveSome surgical procedures such as laryngoplasty require patients to remain conscious during the intraoperative phase in order to enable speech monitoring. Dexmedetomidine and REMIFENTANIL (cas 132875-61-7) were used in this study, since they promote appropriate patient collaboration with facilitated awakening, and are rapidly eliminated.

We also recommend Trading Suppliers and Manufacturers of REMIFENTANIL (cas 132875-61-7). Pls Click Website Link as below: cas 132875-61-7 suppliers

Prev:A physiologically-based model to predict individual pharmacokinetics and pharmacodynamics of REMIFENTANIL (cas 132875-61-7)
Next:Scientific ArticleREMIFENTANIL (cas 132875-61-7)–ketamine vs. propofol–ketamine for sedation in pediatric patients undergoing colonoscopy: A randomized clinical trialREMIFENTANIL (cas 132875-61-7)–cetamina vs. propofol–cetamina para sedação em pacientes pediátricos submetidos à colonoscopia: ensaio clínico randômico)